Sensei Biotherapeutics Inc (SNSE)
0.66
+0.01
(+1.54%)
USD |
NASDAQ |
Jun 25, 16:00
0.66
0.00 (0.00%)
After-Hours: 20:00
Sensei Biotherapeutics Research and Development Expense (Annual): 18.30M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.30M |
| December 31, 2022 | 30.38M |
| December 31, 2021 | 21.66M |
| Date | Value |
|---|---|
| December 31, 2020 | 11.18M |
| December 31, 2019 | 8.35M |
| December 31, 2018 | 8.227M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
8.35M
Minimum
2019
30.38M
Maximum
2022
17.98M
Average
18.30M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals Inc | 4.439B |
| Oragenics Inc | 15.49M |
| Rezolute Inc | 43.81M |
| GT Biopharma Inc | 6.466M |
| IGM Biosciences Inc | 215.52M |